Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-25 @ 4:54 AM
NCT ID:
NCT05396118
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with breast cancer, gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) grades G1, G2 or G3, lymphoma or sarcoma
* Measurable solid tumor of at least 1.5 cm
* Capable of understanding the patient information in Danish and giving full informed consent
Exclusion Criteria:
* Pregnancy
* Breast-feeding
* Weighs above 140 kg and/or with abdominal circumference exceeding the gantry of the PET/MR coil (120 cm)
* History of allergic reaction attributable to compounds of similar chemical or biologic composition to 18F-FDG or pyruvate
* Patients who are unable to lie in the MR scanner for up to 90 minutes
* Pace-maker
* Metallic implantations within the past 6 weeks
* Non-MR compatible implants
* Claustrophobia
* Participants who have not fasted for a minimum of 4 hours prior to the planned scan time
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05396118
Study Brief:
Protocol Section:
NCT05396118